UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 12/2012, Volume 367, Issue 23, pp. 2204 - 2213
GLOMERULAR-FILTRATION-RATE | CONVERTING-ENZYME INHIBITORS | LEFT-VENTRICULAR DYSFUNCTION | MYOCARDIAL-INFARCTION | HEART-FAILURE | DOUBLE-BLIND | CARDIOVASCULAR MORTALITY | FOLLOW-UP | SYSTOLIC DYSFUNCTION | UMCG Approved | BLOOD-PRESSURE | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Diabetes. Impaired glucose tolerance | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Patient Dropouts | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Kidney Diseases - epidemiology | Treatment Failure | Amides - adverse effects | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Hypokalemia | Female | Drug Therapy, Combination | Diabetes Mellitus, Type 2 - complications | Double-Blind Method | Fumarates - therapeutic use | Kidney Diseases - prevention & control | Amides - therapeutic use | Fumarates - adverse effects | Antihypertensive Agents - therapeutic use | Antihypertensive Agents - adverse effects | Renin - antagonists & inhibitors | Hyperkalemia - chemically induced | Aged | Kidney Diseases - etiology | Diabetes Mellitus, Type 2 - drug therapy | Angiotensin Receptor Antagonists - therapeutic use | Myocardial infarction | Women | Creatinine | Cerebral infarction | End-stage renal disease | Stroke | Heart attacks | Kidneys | Diabetes mellitus | Cardiovascular disease | Coronary artery disease | Hypotension | Hyperkalemia | Renin | Angiotensin | Renal failure | Diabetes | Kidney diseases | Cardiovascular diseases | Diabetes mellitus (non-insulin dependent) | Heart diseases | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 3, pp. 232 - 242
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Glycated Hemoglobin A - analysis | Hypoglycemic Agents - therapeutic use | Triazoles - adverse effects | Double-Blind Method | Follow-Up Studies | Administration, Oral | Humans | Kaplan-Meier Estimate | Hospitalization - statistics & numerical data | Pyrazines - therapeutic use | Cardiovascular Diseases - complications | Diabetes Mellitus, Type 2 - blood | Heart Diseases - etiology | Heart Diseases - epidemiology | Pyrazines - adverse effects | Cardiovascular Diseases - mortality | Sitagliptin Phosphate | Diabetes Mellitus, Type 2 - drug therapy | Drug Therapy, Combination | Heart Failure - etiology | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Triazoles - therapeutic use | Type 2 diabetes | Care and treatment | Usage | Clinical trials | Influence | Sitagliptin | Dosage and administration | Cardiovascular diseases | Myocardial infarction | Cerebral infarction | Stroke | Inhibitor drugs | Peptidase | Diabetes mellitus | Pancreatitis | Cardiovascular disease | Angina | Side effects | Pancreatic cancer | Hemoglobin | Diabetes | Health risk assessment | Drug therapy | Diabetes mellitus (non-insulin dependent) | Heart diseases | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 01/2015, Volume 385, Issue 9965, pp. 351 - 361
Internal Medicine | LDL CHOLESTEROL | HIGH-DOSE ATORVASTATIN | METAANALYSIS | STATIN THERAPY | ASSOCIATION ANALYSES | DISEASE | PREVENTION | BODY-MASS INDEX | RISK | MENDELIAN RANDOMIZATION | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Body Mass Index | Genetic Testing | Cholesterol, HDL - metabolism | Diabetes Mellitus, Type 2 - genetics | Humans | Middle Aged | Risk Factors | Male | Body Weight - genetics | Randomized Controlled Trials as Topic | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Cholesterol, LDL - metabolism | Polymorphism, Single Nucleotide - genetics | Female | Aged | Hydroxymethylglutaryl CoA Reductases - genetics | Type 2 diabetes | Genetic research | Enzymes | Thiols | Diabetes | Low density lipoprotein | Statins | Cholesterol | Risk factors | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 375, Issue 9716, pp. 735 - 742
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Diabetes. Impaired glucose tolerance | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Age Distribution | Age Factors | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Anticholesteremic Agents - adverse effects | Diabetes Mellitus, Type 2 - epidemiology | Randomized Controlled Trials as Topic | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Female | Aged | Diabetes Mellitus, Type 2 - chemically induced | Complications and side effects | Dosage and administration | Diabetes | Research | Risk factors | Statins | Heart failure | Heart attacks | Sensitivity analysis | Hemodialysis | Cardiovascular disease | Clinical medicine | Patients | Meta-analysis | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2003, Volume 349, Issue 20, pp. 1893 - 1906
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiovascular system | Biological and medical sciences | Miscellaneous | Medical sciences | Pharmacology. Drug treatments | Myocardial Infarction - mortality | Valsartan | Angiotensin Receptor Antagonists | Humans | Middle Aged | Male | Ventricular Dysfunction, Left - mortality | Captopril - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - mortality | Female | Captopril - adverse effects | Drug Therapy, Combination | Heart Failure - etiology | Heart Failure - mortality | Double-Blind Method | Valine - analogs & derivatives | Ventricular Dysfunction, Left - etiology | Heart Failure - drug therapy | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Ventricular Dysfunction, Left - drug therapy | Tetrazoles - therapeutic use | Valine - therapeutic use | Aged | Tetrazoles - adverse effects | Valine - adverse effects | Heart failure | Evaluation | Captopril | Angiotensin II receptor blockers | Drug therapy | ACE inhibitors | Heart attack | Hypertension | Hypotheses | Heart attacks | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2012, Volume 367, Issue 22, pp. 2089 - 2099
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | General aspects | Biological and medical sciences | Myocarditis. Cardiomyopathies | Medical sciences | Coronary heart disease | Cholesterol Ester Transfer Proteins - antagonists & inhibitors | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Risk | Secondary Prevention | Biomarkers - blood | Apolipoproteins - blood | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Sulfhydryl Compounds - adverse effects | Anticholesteremic Agents - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - mortality | Cholesterol, HDL - blood | Cholesterol, LDL - blood | Female | Aged | Blood Pressure - drug effects | Sulfhydryl Compounds - therapeutic use | C-Reactive Protein - analysis | Measurement | Cholesterol, HDL | Patient outcomes | Dosage and administration | Research | Acute coronary syndrome | Drug therapy | Health aspects | Cardiovascular agents | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | C-reactive protein | Heart attacks | Mortality | Cardiovascular disease | Angina | Coronary artery disease | Cholesterol | Cholesteryl ester transfer protein | Studies | Ischemia | Diet | Biomarkers | Blood pressure | Acute coronary syndromes | Cardiovascular diseases | Heart diseases | Lipoproteins (high density) | Index Medicus | Abridged Index Medicus
Journal Article